Cao K, Wei S, Ma T, Zou X, et al. RFX2-BNIP3 axis-driven adaptive mitophagy promotes resistance to ACK1-targeted therapy in non-small cell lung cancer. Oncogene 2025 Jul 25. doi: 10.1038/s41388-025-03502.
PMID: 40715489